ArticleClinical & experimental metastasis2018
The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Shiue-Wei Lai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it